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The objective of this thesis was to investigate the relationship of personality and stress with 
subsequent risk of Parkinson’s disease (PD).  
In Study I, we conducted a population-based cohort study using questionnaire data from the 
Swedish Twin Registry to explore whether the personality traits, neuroticism and 
introversion, were associated with later PD risk. We also explored the role of smoking as a 
mediator in the relationship between personality and PD. Both neuroticism and introversion 
were associated with an increased PD risk. Further, smoking was a significant mediator in the 
relationship between personality traits and PD that partly accounted for the effect of 
introversion, whereas it acted as a suppressor for the effect of neuroticism on PD risk.  
In Study II, we wanted to further explore the main findings from study I, with the aim to 
examine whether the observed associations between neuroticism, smoking and PD may be 
causal. We conducted a two-sample Mendelian randomization study in a network framework, 
consisting of three main analyses: (I) causal effect of neuroticism on PD, (II) causal effect of 
neuroticism on smoking initiation, (III) causal effect of smoking initiation on PD. We found 
no support for a causal association between neuroticism and PD risk. On the other hand, the 
results indicated that the association between neuroticism and smoking initiation is causal and 
that there is a strong causal effect of smoking initiation on a reduced PD risk.  
In Study III, we explored the association between occupational stress according to the job 
demands-control model and risk of PD. We conducted a population-based cohort study 
including individuals born in Sweden between 1920 and 1950 who had an occupation in 1980 
or 1970. Levels of job demands and control were determined using a job-exposure matrix. 
High job demands was associated with increased PD risk in men, especially in men with high 
education, whereas high job control was associated with increased PD risk among low 
educated, more strongly in women. High-strain jobs (high demands and low control) were 
only associated with increased PD risk among men with high education, whereas active jobs 
(high demands and high control) were associated with increased PD risk among men with 
low education. 
In Study IV, we conducted a population- and sibling-matched cohort study to investigate the 
association between stress-related disorders and neurodegenerative diseases. Stress-related 
disorders (i.e. post-traumatic stress disorder (PTSD), acute stress reaction, adjustment 
disorder, and other stress reactions) and neurodegenerative diseases (classified as primary and 
vascular neurodegenerative diseases, as well as Alzheimer’s disease (AD), PD, and 
amyotrophic lateral sclerosis (ALS)) were identified through the national patient register. We 
found that stress-related disorders were associated with increased risk of neurodegenerative 
diseases in general. The association was stronger for vascular neurodegenerative diseases, 
which might indicate importance of a cerebrovascular pathway. A statistically significant 
association was found for AD alone, but not for PD or ALS, although the estimates pointed in 
the same direction.  
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1 INTRODUCTION – A HISTORICAL BACKGROUND 
 
“It would seem that paralysis agitans affected mostly those persons whose lives had been 
devoted to hard work… The people who take their work to bed with them and who never 
come under the inhibiting influences of tobacco or alcohol are the kind that are most 
frequently affected. In this respect, the disease may be almost regarded as a badge of 
respectable endeavor.”1  
- C.D. Camp, 1913 
Paralysis agitans, the disease mentioned in the quotation above, was first described by James 
Parkinson (1755-1824), a London surgeon, paleontologist, geologist and political activist. 
However, today he is most known for his work ‘An Essay on the Shaking Palsy’ from 1871 
in which he provided detailed descriptions of cases suffering from a neurological syndrome 
defined by a combination of motor symptoms; ‘Involuntary tremulous motion, with lessened 
muscular power, in parts not in action and even when supported; with a propensity to bend 
the trunk forward, and to pass from a walking to a running pace: the senses and intellects 
being uninjured’.2 
Some decades later, Jean-Martin Charcot (1825-1893) continued Parkinson’s work, by 
providing more thorough and refined descriptions of the clinical aspects of the disease (for 
example he distinguished bradykinesia from weakness, and resting tremor from action 
tremor). He also suggested the disease should be renamed to Parkinson’s disease (PD).3 
Charcot is generally considered to be one of the founders of modern neurology, but may be 
most remembered for his today controversial work on hysteria and hypnosis, which later 
influenced Sigmund Freud. At that time, the neuropathology of PD was not known, however, 
Charcot considered PD to be a “névrose” - at that time broadly defined as a disorder of the 
nervous system without a definitive lesion. He further hypothesized emotional stress as a 
precipitant to PD and described cases where PD was induced after exposure to traumatic 
events.4 The idea of emotional stress as a risk factor for PD was later supported by Pierre 
Janet (1859-1947), a contemporary of Freud, who described similar cases as Charcot where 
PD was induced after strong emotional reactions to traumatic events.5  
The opening quotation above by Camp from 1913 is often referred to as the first mentioning 
of a common personality profile among people with PD.6-8 He further identified common 
features such as industriousness and morality among persons with PD.1 A pre-morbid 
personality in PD, sometimes referred to as the parkinsonian personality, continued to be 
discussed during the first half of the 20th century. In these works, the parkinsonian personality 
was interpreted within a psychoanalytical framework and often described pejoratively as 
rigid, tense, neurotic, compulsive, conform, introspective and emotionally repressed.9-13 
However, words like ambitious, hard-working, trustworthy, conscientious, thorough, 
altruistic, independent, law-abiding, responsible, honest and family-oriented also occured.11-13 
 
2 
The parkinsonian personality was believed to cause an inner imbalance or tension due to, on 
one side striving for independence and freedom, while on the other side having high moral 
standards, a will to follow social norms and being overly self-controlled. This was 
hypothesized to have a direct effect on PD pathogenesis through excessive inhibition of 
emotions, impulses and intrinsic drives leading to an ‘over-activation’ in the brain ultimately 
manifesting in motor symptoms.9-11 Some authors also used the term ‘masked personality’ by 
which they meant people with PD hid hostile and aggressive impulses.10 11 
Similar ideas were expressed as late as until the 1970s.12 13 Persons with PD were described 
as rigid, inflexible and having a difficulty in coping with emotional stress.12 Others 
considered persons with PD to share a common compulsive-neurotic character and a lack of 
self-assertiveness. Thus, being dependent on job-achievement to assert themselves and 
therefore as a group they tended to work hard also during spare time.13 It was concluded that 
emotional and behavioral patterns (e.g. inward aggression and inhibition of impulses) 
established during early childhood, as an important period for both emotional and motor 
system development, could lead to an increased susceptibility to PD.12 13 However, there were 
also early studies concluding that no pre-morbid parkinsonian personality exists.14 15 
Although common personality features were identified among persons with PD, these were 
interpreted as an initial reaction to receiving the diagnosis15 or a consequence of living with 
the disease.14  
The referred literature above represents the first notions of a potential association of 
personality and stress with PD risk and illustrates how this idea was formed and continued to 
be discussed for many decades. Much of this work was based on anecdotal observations and 
often interpreted within a theoretical framework that lacks scientific relevance in today’s 
view. The parkinsonian personality was also often described in stigmatizing ways, in which 
motor symptoms such as rigidity or hypomimia (reduced facial expression) were seen as 
physical representations of a rigid mind, a lack of affect and emotional inhibition. These 
pieces of work could easily be criticized for being speculative. However, this literature is 
interesting from a historical perspective. Despite the insufficient and defective scientific value 
of these early studies, the idea of an association between personality, stress and PD risk is still 
being discussed. More recently, controlled studies, using standardized measures have been 
performed but epidemiological evidence is still scarce. 
With this introduction, I wanted to set the historical context of the overall theme of this thesis. 
To conclude, the hypothesis of an association between personality, stress and risk of PD has 
been smoldering for a very long time, but as epidemiology many times has taught us: where 





2.1 PARKINSON’S DISEASE 
PD is the second most common neurodegenerative disorder and the most common movement 
disorder, estimated to affect about six million people worldwide (in 2016).16 In Sweden, 
about 22,000 individuals are affected.17 PD is an age-related disorder, with a median age of 
onset of 60-65 years. The prevalence is estimated at 0.3% in the general population of 
industrialized countries, 1% in those older than 60 years, rising to 3% in those older than 80 
years.18 Apart from age, male sex is an important risk factor. Men are at about 50% higher 
risk than women.19 PD is a multifactorial and heterogeneous disease, with a long preclinical 
period and the underlying mechanisms causing the disease remain unclear. 
2.1.1 Symptoms and diagnosis 
Parkinson’s disease is a movement disorder with three cardinal motor symptoms; 1) resting 
tremor (involuntary shaking (4-6 Hz) of a limb or other body part when at rest), 2) rigidity 
(stiffness of muscles and joints due to hypertonia, i.e. too much muscle tone), and 3) 
bradykinesia (slowness of voluntary movements). Postural instability is also common but 
does not always count as a cardinal symptom and usually occurs late in the disease course.  
Diagnosis of PD is based on clinical criteria as there are no reliable biomarkers or specific 
neuroimaging techniques available for the clinical diagnosis of PD. Several sets of clinical 
diagnostic criteria for PD have been proposed.20-22 Essentially, they are all based on the 
presence of cardinal motor symptoms and signs of PD, but differ slightly in which 
combination is required to fulfill the diagnosis criteria of PD. They also contain different 
exclusion and supportive criteria. Examples of exclusion criteria are secondary parkinsonism 
induced by identified causes (e.g. vascular- or drug-induced) or alternative diagnoses of 
atypical parkinsonism. In PD there is normally an asymmetrical onset of motor symptoms, 
which appear slowly and gradually progress. Further, response to antiparkinsonian drugs is 
usually included as a supportive criterion.   
Although PD is primarily a movement disorder, non-motor symptoms are also common and 
may occur in both clinical and preclinical stages of PD. Non-motor symptoms common in PD 
include hyposmia, constipation, rapid eye movement sleep behavior disorder (RBD), 
excessive daytime sleepiness and psychiatric symptoms such as depression and anxiety, as 
shown in a recent meta-analysis.23 This is an important aspect of the disease, as these 
symptoms significantly contribute to disability independent of the severity of motor 
symptoms24 and adversely affect the quality of life.25 Non-motor symptoms that arise in the 
preclinical stage of PD are commonly referred to as prodromal or pre-motor symptoms. 
2.1.2 Pathology 
Neuropathologically, PD is characterized by a selective degeneration of dopaminergic 
neurons in the substantia nigra pars compacta causing a dopamine deficiency in the striatum 
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which results in the typical motor symptoms. PD is also characterized by the presence of 
Lewy pathology (Lewy bodies and Lewy neurites), which are intraneuronal inclusions 
consisting of a large number of proteins in which ubiquitin and α-synuclein are main 
components.26 27 α-synuclein is a small soluble protein mainly located in the presynaptic 
nerve terminals with a propensity to miss-fold and self-aggregate, become insoluble and 
eventually leading to  Lewy pathology. Although Lewy bodies are related to neuronal 
degeneration, their role in neurodegeneration is not well understood. Whereas there are 
indications that the intermediates in the aggregation process (e.g. oligomeric and proto-
fibrillar forms of α-synuclein) are cytotoxic, Lewy body formation may represent a 
neuroprotective mechanism.27 28 Increasing evidence suggests that misfolded α-synuclein 
might spread between neurons in a prion-like manner.29 Further, according to autopsy studies, 
hypotheses have been suggested (known as Braak’s or the dual-hit hypothesis) that PD may 
start with Lewy pathology in the peripheral enteric nervous system and the olfactory bulb 
which is supposed to be initiated by an unknown pathogen (potentially a virus) entering 
through the gut or nasal cavity. The Lewy pathology is then supposed to spread in a specific 
pattern via the vagus nerve and olfactory tract toward/within the central nervous system 
following six stages.30 31 However, this is still controversial. Although nigrostriatal dopamine 
deficiency is the major hallmark of PD, alterations in cholinergic, serotonergic and 
noradrenergic neurotransmission have all been observed in PD and are related to psychiatric 
and other non-motor symptoms of the disease.32 
PD is a slowly progressing disorder in which the neurodegeneration starts many years before 
the first symptoms appear. It has been estimated that motor signs first appear when about 30-
70% of the dopaminergic neurons are already lost.33 Based on extrapolation of nigrostriatal 
loss from autopsy studies and dopamine imaging techniques, the preclinical period has 
commonly been estimated at 5-6 years.34 Epidemiological studies also suggest a longer 
preclinical period defined by the presence of pre-motor symptoms.23 Further, some of these 
pre-motor symptoms may be present at least two decades before clinical PD diagnosis, and 
the timing of these symptoms (e.g. constipation, RBD, hyposmia) have been linked to the 
spread of α-synuclein pathology in the early preclinical Braak stages.34-36 
2.1.3 Etiology 
The etiology of PD is largely unknown, but most likely multifactorial involving both genetic 
and environmental factors.37 38 The vast majority of PD cases appear sporadic, although there 
are rare monogenic forms of PD in which mutations in specific genes can be directly 
implicated and have been linked to autosomal dominant or recessive forms of PD. 
Monogenic (mostly familial) forms of PD account for less than 5% of the overall number of 
PD cases.39 However, genetic factors are important also for sporadic PD. A meta-analysis 
reported that individuals having a first-degree or any relative with PD have a more than three 
times higher risk of PD, although this may indicate importance of both genetics and shared 
environment.40 In twin studies it is possible to distinguish between genetic and environmental 
effects, given that monozygotic twins share the whole genome while dizygotic twins share on 
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average half of the segregating genes. In a Swedish longitudinal twin study the (narrow-
sense) heritability of PD was estimated at 34%.41 Furthermore, a recent genome-wide 
association study (GWAS) meta-analysis identified 90 independent single nucleotide 
polymorphisms (SNPs) across 78 genomic loci and reported a SNP-based heritability of 
22%.42 
Still, environmental factors are believed to be most important for sporadic PD. However, 
much remains to be explored regarding identifying which these factors are and quantifying 
their effects. A previous report on consensus opinions by experts43 and an extensive literature 
review44 on the topic have been published, both of which evaluated the strength of evidence 
according to the terminology of the Institute of Medicine. Environmental factors associated 
with PD at an at least limited evidence level according to these papers are listed in Table 1. 
These conclusions are consistent with results from a more recent meta-analysis on various 
environmental exposures and PD risk.40 In general, the evidence is limited and/or 
inconclusive for many environmental factors related to PD. In contrast, the negative 
association between smoking and PD is well established.40 45-49 
  
Table 1. Environmental factors associated with PD risk and evaluated levels of evidence according to a previous 
literature review44 and a report based on expert consensus opinions.43 







Traumatic brain injury43 
Dairy products43 44 
Physical activity43 44 
Dietary antioxidants44 
High blood urate levels43 
NSAIDs*43 
Alcohol44 
* Nonsteroidal anti-inflammatory drugs (NSAIDs) 
 
Environmental factors associated with increased or decreased PD risk are (for simplicity) 
commonly referred to as risk or protective factors. However, it is important to keep in mind 
that most results are derived from observational studies and that association, therefore, does 
not infer causality. Observational studies are always subjected to confounding to some 
degree. Moreover, given that PD has a late onset and a long prodromal phase, one must 
consider the possibility of reverse causality. Differentiating pre-motor symptoms from risk or 
protective factors is not straightforward. There are for example hypotheses that the inverse 
association between smoking and PD represents prodromal changes in PD, e.g. a reduced 
response to nicotine making it easier to quit smoking in prodromal phases of PD.50 
Personality traits and stress have also been related to subsequent PD, which will be discussed 




2.2 PERSONALITY TRAITS 
Personality is what makes us unique and the reason why we can say we ‘know’ someone – 
there is something stable and predictable in how people tend to react and behave in a given 
situation. Personality has historically often been described in terms of fixed categories, i.e. 
personality types. Personality states, on the other hand, represent temporary behaviors or 
feelings, and state theories usually emphasize environmental influences on fluctuations in 
behavior. However, the dominating approach to study differences in personality is using 
traits. Personality traits can generally be described as ‘relatively enduring patterns of 
thoughts, feelings, and behaviors that distinguish individuals from one another’.51 As most 
trait models rely on factor analysis, the derived dimensions are also referred to as factors. 
Two of the most used factor models of personality in research are Eysenck’s two-factor 
model and the big five-factor model (FFM).52 53 
Eysenck assumed that differences in personality have a biological basis and favored the use 
of few uncorrelated factors. Based on factor analysis he derived two broad dimensions of 
personality - neuroticism and extraversion/introversion.54 Later he added a third factor 
(psychoticism) which, however, was shown to be correlated with other factors. By linking 
results from experimental psychology to personality he aimed to identify the biological basis 
of personality. He related extraversion/introversion to cortical excitation and inhibition, 
hypothesizing that introverts react more quickly and generate stronger excitation at a given 
stimulus compared to extroverts, whereas inhibition in introverts is weaker and generated 
more slowly compared to extraverts. Neuroticism was related to the autonomic nervous 
system due to its relationship with emotional reactions.52 54 Although the theory behind this 
model has been criticized, the identified dimensions neuroticism and 
extraversion/introversion seem to emerge in most personality inventories.52 53    
In contrast, the FFM is not supposed to represent any specific underlying theory of 
personality. It is derived from analyses of natural-language words used to describe self and 
others (mostly adjectives), under the assumption that language would encode all traits that are 
of importance. The FFM was developed to represent as much of the variability in individuals’ 
personalities as possible by using few uncorrelated factors (or dimensions) and is the result of 
decades of work by different research groups. Although different models including different 
number of factors have been proposed over the years, many researchers now seem to agree on 
the FFM consisting of the five broad dimensions; neuroticism, extraversion, openness, 
agreeableness and conscientiousness.53 55-57 Further, this model seems to be universal as the 
same factor structure emerges in studies performed in different languages and cultures.58    
2.2.1 Neuroticism and Introversion 
As mentioned, neuroticism and introversion (i.e. the inverse of extraversion) are two main 
dimensions of personality that emerge in most models of personality, including Eysenck’s 
and the FFM. Neuroticism (also referred to as emotional stability/instability) is defined by a 
proneness to experience negative emotions and thoughts such as anxiety, sadness and fear, 
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whereas introversion is defined by low levels of activity, assertiveness, excitement-seeking, 
sociability and positive emotions.  
Studies have shown that these traits are relatively stable through adulthood and have a 
moderate genetic component.59-62 In a meta-analysis, the heritability for both neuroticism and 
introversion was estimated at about 40%.60 A large GWAS meta-analysis of neuroticism 
recently identified 136 independent loci indicating that neuroticism is highly polygenic.61  
2.2.2 The ‘parkinsonian personality’? 
As outlined in the introduction, the term ‘parkinsonian personality’ has repeatedly occurred in 
the literature. However, a distinct ‘parkinsonian personality’ type has never been clearly 
defined, mainly due to a lack of standardized measures of personality and methodological 
limitations in older studies. 
More recently the hypothesis of an association between personality and PD has gained further 
support.63-65 Several observational studies have examined the association between personality 
traits and PD in a more standardized and controlled manner. Most studies have used 
personality assessment tools based on Cloninger’s temperament model including the three 
dimensions novelty-seeking, harm-avoidance and reward dependence.66 Overall, PD has been 
associated with lower levels of novelty-seeking and higher levels of harm-avoidance.63-65 
However, studies based on Cloninger’s model were all case-control studies and most of them 
did not intend to measure premorbid personality, and those who did assessed premorbid 
personality retrospectively. Harm-avoidance is highly correlated with both neuroticism and 
introversion, whereas novelty-seeking is inversely correlated with introversion.67 However, 
few studies have examined these traits in relation to PD. Nevertheless, in two longitudinal 
studies with up to four decades of follow-up, it was shown that neuroticism, but not 
introversion, was associated with risk of PD.68 69 
Altogether, despite the varying models and measures of personality that have been studied in 
relation to PD, there seems to be some convergence between the traits associated with PD. 
Whether these traits are present before PD onset is less clear, as most studies were 
retrospective case-control studies and subjected to recall bias. Therefore, more prospective 
studies with long follow-up periods are needed. Still, given the long prodromal period of PD, 
reverse causation is difficult to rule out. Personality changes could represent pre-motor 
aspects of PD, rather than being a risk factor.  
2.2.3 Neuroticism, health and PD 
Neuroticism is the personality trait that most consistently has been associated with poorer 
health and three main general hypotheses have been proposed to explain this association.70-72 
The first hypothesis implies that neuroticism causes adverse health outcomes potentially 
through mediation by unhealthy behaviors such as smoking, high alcohol consumption and 
substance abuse. There is, for example, a well-documented positive association between 
neuroticism and smoking.73 74 However, there is also a well-documented association between 
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smoking and reduced PD risk.45 Thus, what factors that would mediate the potential 
association between neuroticism and PD is less clear.  
The second hypothesis is reverse causation, meaning that illness and poor health causes 
individuals to display more neuroticism.72 In the context of PD, which has a long prodromal 
period, premorbid personality changes could represent pre-motor aspects of PD, rather than 
being a risk factor. Interestingly, it has also been suggested that reverse causation explains the 
inverse association between smoking and PD, due to prodromal changes that may lead to an 
ease of quitting smoking or less likelihood to start smoking (e.g. less reward from nicotine 
stimulation).50  
Third, individuals with high neuroticism levels may perceive and report symptoms to a 
greater extent without having the actual disease to a greater extent.72 Although it is unlikely 
that neuroticism will be misclassified as PD, high neuroticism levels could potentially lead to 
an earlier diagnosis. 
Alternatively, associations between neuroticism and various health outcomes could be 
explained by genetic confounding. High neuroticism has particularly been associated with 
mental health problems and psychiatric disorders such as depressive symptoms, lower 
subjective well-being, major depressive disorder, anxiety-disorders and schizophrenia, which 
in part is due to genetic correlation.62 There is no evidence for a genetic correlation between 
neuroticism and PD.75  
Within the definition of neuroticism lies a vulnerability to stress as an increased tendency to 
react with negative emotions to stressful events. Neuroticism has also been associated with an 
increased risk of experiencing stressful events and with passive and ineffective ways to cope 
with stress.71 76 Stress has been associated with various adverse health outcomes, and could 
potentially be a mediator between neuroticism and PD. However, the association between 




Stress is a frequently used term in mass media and everyday language which could have 
several different meanings; both positive and negative. Stress is a very broad concept that 
incorporates both the external stimuli or exposure, a so called “stressor” and the resultant 
“stress response” that may be both psychological (emotional, behavioral, cognitive) and 
physiological (e.g. changes in stress hormones and neurotransmitters). Further, multiple 
individual factors influence how stressors are perceived and coped with, such as early life 
experience, sex, personality, social support, prior psychiatric history and various 
sociodemographic variables.77 Therefore, there are several models and definitions in use that 
emphasize different aspects of stress. Lazarus and Folkman (1984) provided a transactional 
model of stress integrating individual and environmental factors and defined psychological 
stress as follows: “Psychological stress is a particular relationship between the person and the 
environment that is appraised by the person as taxing or exceeding his or her resources and 
endangering his or her well-being”.78  
Another influential theory of stress is the “allostatic load theory” which explains how the 
stress response may have either beneficial or damaging effects on the body by using the 
concepts of “allostasis” and “allostatic load”.79 It is vital for humans to maintain a stable 
internal environment (homeostasis) to function and survive. “Allostasis” refers to the 
adaptive biological processes that serve to maintain homeostasis when the external or internal 
environment is changing. It is believed that allostasis has evolved to increase the body’s 
ability to cope efficiently with any threats and challenges we are exposed to. On the other 
hand, “allostatic load” refers to situations where allostatic systems are overstimulated, usually 
as a consequence of repeated or prolonged stress (i.e. chronic stress) or dysregulated (failure 
to shut off or respond adequately), which could have damaging effects on many physiological 
systems.79 80  
The main physiological stress response involves activation of the sympathetic nervous system 
and the hypothalamic-pituitary-adrenal (HPA) axis resulting in release of the stress hormones 
catecholamines (mainly adrenaline and noradrenaline) and corticoids (mainly cortisol), 
respectively. The sympathetic nervous system reacts rapidly in response to acute stress and 
regulates a range of essential functions including cardiovascular, respiratory, and endocrine 
function seen in the fight-or-flight response.81 The HPA axis response is characterized by 
hypothalamic release of corticotropin-releasing factor (CRF) and arginine vasopressin into 
blood vessels connecting the paraventricular nucleus of hypothalamus with the anterior 
pituitary gland, where it stimulates the secretion of adrenocorticotropic hormone (ACTH). 
ACTH then binds to receptors in the adrenal cortex to stimulate the release of large quantities 
of cortisol, which exerts its effects on multiple tissues and involves multiple physiological 
processes (e.g. metabolic, immune and cardiovascular).81 During acute stress, these pathways 
stimulate target systems leading to e.g. increased oxygenation and nutrition in the brain, 
heart, and skeletal muscles, which may be beneficial to cope with potentially dangerous or 
threatening situations. However, chronic and repeated stress may lead to dysregulation of the 
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HPA axis and altered cortisol levels, which is associated with many adverse health effects, 
including mood disorders, cardiovascular, metabolic, and inflammatory disorders.82  
2.3.1 Measures of stress 
There are many definitions of stress and consequently many different ways to measure stress. 
Perceived stress is perhaps most commonly used and is usually assessed by different rating 
scales. However, measures of stress can also be related to exposure to a stressor, or to 
symptoms or disorders related to the stress response. In this project two different indicators of 
stress were used, occupational stress defined by the job-control-demand model measured by a 
job-exposure matrix, and a diagnosis of a stress-related disorder. As outlined in the 
introduction of this thesis, stress was actually one of the first suggested risk factors for PD. 
Intriguingly, this early work also touched upon specific aspects of stress related to this thesis. 
A severe response to trauma exposure was actually one of the earliest suggested risk factors 
for PD and people with PD were often described as hard-working, with a generally unhealthy 
attitude towards performance and job-achievement. 
2.3.2 Occupational stress 
Work-related stress might be an important indicator of the overall exposure to stress during 
adulthood as most adults spend much of their time at work. Work stress may refer to the 
conditions that induce some kind of stress response, or the actual stress-response in itself.83 
Work conditions that may induce stress include both physical (workload, working hours), 
psychosocial (conflicts, bullying, harassment) and organizational factors (job insecurity, 
work-family conflict). 
The job demand-control model84 85 is one of the most influential models of work stress, 
aiming to explain how work conditions may lead to stress response and adverse health 
consequences. The job-demand dimension reflects workload and time pressure, whereas the 
job-control dimension measures skill discretion and decision authority and reflects to what 
extent the worker can influence its own social work environment, task content, pace and 
schedule. According to the model, low control, high demands and especially the combination 
of these are hypothesized to cause job strain (a stress response) and predict adverse health 
outcomes.86 According to this model, jobs can be classified as high strain jobs (high demands 
and low control), low strain jobs (low demands and high control), active jobs (high control 
and high demands), or passive jobs (low demands and low control). High strain jobs are 
supposed to entail the highest health risk whereas low strain jobs are supposed to be 
associated with the lowest risk. This model has shown to predict various health outcomes 
including cardiovascular disease, psychiatric disorders, and musculoskeletal problems,87-90  
but has previously not been studied in relation to PD.  
In the work of this thesis, we used a job-exposure matrix to assess levels of job demands and 
job control. Thus, occupational stress in this thesis refers to stress-levels applied to an 
individual based on his or her specific job title (i.e. where work stress levels in one individual 
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is measured by how individuals having the same specific job title on average scored job 
demands and control). 
2.3.3 Stress-related disorders 
Stress-related disorders are defined not only by their symptoms but also by the presence of at 
least one causative stressor. These diagnoses can be used as a measure of a severe stress 
response. A stressful life-event and the resultant psychological distress might lead to a 
diagnosis of adjustment disorder whereas a threatening traumatic event might lead to an 
immediate and transient acute stress reaction or chronic post-traumatic stress disorder 
(PTSD).91 These disorders are supposed to arise as a direct consequence of an acute and 
severe or chronic or repeated stressor, in contrast to situations where stress events may 
contribute to the presentation of a disorder but the etiological importance is less clear. 
Stress-related disorders are common psychiatric disorders92 and have been associated with 
several long-term physiological health consequences, predominantly cardiovascular 
diseases.92-94 Regarding the association between stress-related disorders and 
neurodegenerative diseases, studies of male veterans95-98, as well as two recent cohort studies 
of the general population99 100, have demonstrated that PTSD is associated with an increased 
risk of dementia. Recently, evidence was also provided for an association between all stress-
related disorders and risk of dementia.101 However, less is known about the relationship 
between stress-related disorders and other neurodegenerative diseases. However, PTSD102 103 
and adjustment disorder104 were shown to be associated with an increased PD risk, whereas 
stress-related disorders were not found to be associated with ALS risk,105 but this is clearly 
under explored.   
2.3.4 Stress and Parkinson’s disease 
Chronic stress and a dysregulated stress response have been suggested in experimental 
studies to influence the pathogenesis of neurodegenerative diseases106-108 and have been 
suggested as a potential risk factor for PD.109-111  
The hypothesis of stress as a risk factor for PD has received some support from experimental 
animal studies. For example, it has been found that exposure to chronic unpredictable stress 
in addition to 6-hydroxydopamine (6-OHDA) in a rat model of PD caused greater loss of 
dopamine neurons and greater motor deficits.112 Another study on the 6-OHDA rat model of 
PD found that chronic restraint stress and corticosterone treatment could impair motor 
function and accelerate nigral neuronal loss independent of each other.113 Further, pre-
treatment with corticosterone at doses chosen to mimic physiological stress caused an 
enhanced neuroinflammatory response to methamphetamine and increased dopaminergic 
neurotoxicity in mice.114 A study using the lipopolysaccharide (LPS) model of PD showed 
that exposure to chronic stress prior to LPS treatment resulted in a higher inflammatory 
response, associated with more severe degeneration of dopaminergic neurons and more 
characteristic features of PD.115 Further, pre-exposure of chronic restraint isolation to 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice caused  more severe motor 
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deficits, and  a reduced ability to acquire normal motor function correlated with severe 
depletion of dopaminergic neurons in the SN.116 
However, there are few epidemiological studies on stress and risk of PD, and the results have 
so far been inconclusive.104 117-119 For example, studies on the effect of major life events on 
PD risk have shown both negative, 117 positive118 and no119 association with PD. ‘Vital 
exhaustion’119 (a state of excessive fatigue and irritability often attributed to stress) has been 
associated with increased PD risk. Further, as already mentioned, a few studies have 
associated stress-related disorders (adjustment disorder and PTSD) with increased PD risk.102-
104 Chronic stress is related to psychiatric disorders, including depression and anxiety, which 
are common in PD.120 121 Depression has been shown to precede clinical PD diagnosis,122 123 





The overall aim of this project is to explore the relationships between personality, stress and 
risk of PD. Within this framework the following specific objectives will be addressed: 
 
I.  To explore the association of the personality traits neuroticism and introversion with 
subsequent risk of PD using cohort data from the Swedish twin registry (STR).  
II.  To examine the causal association between neuroticism and PD and the role of 
smoking as a potential mediator in this relationship using a Mendelian randomization 
approach and genome-wide association (GWAS) summary statistics. 
III.  To explore the association between occupational stress according to the job-demand-
control model and risk of PD using population-based cohort data. 
IV. To investigate stress-related psychiatric disorders as a measure of a severe stress 
response in relation to subsequent risk of PD and other neurodegenerative disorders 







4 DATA SOURCES AND MEASUREMENTS 
4.1 REGISTER BASED STUDIES 
Study I, III, and IV were conducted based on record linkage of multiple Swedish national 
health and population registers, national censuses and the Swedish twin registry (STR). This 
was enabled through the unique personal identity number, which has been assigned to all 
Swedish residents since 1947.124 
4.1.1 National Register data 
The national patient register (NPR) held by the National Board of Health and Welfare was 
started in 1964 and initially covered 6 of 26 counties in Sweden. The register gradually 
expanded and in 1976 it covered more than 50% of the in-patient care. Since 1987 it has 
complete nationwide coverage and contains information about discharge records from all 
hospitals in Sweden. Since 2001, the NPR also includes all outpatient specialist care, from 
both public and private caregivers. Information in the NPR includes one primary diagnosis 
and up to eight secondary diagnoses coded according to the International Classification of 
Diseases (ICD) and date of admission/visit and discharge.125  
The cause of death register (CDR) held by the National Board of Health and Welfare 
contains information from death records, including date and place of death, underlying cause 
of death and contributory causes coded according to the ICD. The CDR became digitalized in 
1961 and is annually updated since then, but records between 1952 and 1960 were compiled 
retrospectively and the coverage of CDR is virtually complete since 1952.126 
The total population register (TPR) maintained by Statistics Sweden contains data on life 
events including birth, death, place of death, civil status, migration within Sweden, 
emigration and immigration with almost complete coverage of the Swedish population.127 
The TPR constitutes the basis of the nation-wide cohort studies Study III & IV. 
The Swedish multi-generation register (MGR) is part of the TPR and holds information on 
(biological and adoptive) parents for index persons who are defined as those born 1932 and 
later and lived in Sweden at any point since 1961.128 The MGR contains almost all Swedish 
residents and can therefore be used to represent the Swedish general population and 
constitutes the basis of the nation-wide sibling cohort in Study IV.  
The longitudinal integration database for health insurance and labor market studies (LISA) 
held by Statistics Sweden is a register-based longitudinal database which includes 
socioeconomic data about the adult Swedish population (aged ≥ 16 years) from 1990 and 
onwards (since 2010 individuals aged ≥ 15 years). Among others, it includes information on 




The population and housing censuses were performed between 1960 and 1990 by Statistics 
Sweden. Each decade census questionnaires were sent to all Swedish residents older than 16 
years at the time of the census. Responding to these questionnaires was mandatory, thus the 
response rate was very high (>99% in 1970 and 1980).130 131 The questionnaires included 
detailed information on housing, civil status, occupation, education, income, and social class. 
4.1.3 The Swedish Twin Registry 
The Swedish Twin Registry (STR) was initiated in the 1950’s with the aim to study adverse 
health effects of smoking. It is one of the largest and oldest population-based twin registries 
in the world and contains a collection of different birth cohorts. Study I was based on a birth 
cohort of same-sexed twins born 1926-1958 from the STR. These twins were contacted by 
mailed questionnaires in 1973 collecting data on demographics, medical history, lifestyle 
factors and personality among other things.132 133 In study I, we also used data from the 
Screening Across the Lifespan Twin study (SALT), including follow-up data on smoking for 
twins born 1886-1958 who were interviewed in 1998-2002.133 
4.1.4 Exposures 
 
4.1.4.1 Neuroticism and introversion 
In study I, information on personality was collected as part of the questionnaire sent out in 
1973, when the respondents were between 15 and 48 years old. This questionnaire included a 
short form of the Eysenck Personality Inventory, comprising 18 items 9 each from the 
neuroticism and introversion scales (see appendix). To be included in the study, individuals 
had to respond to at least 6 items on either trait. For respondents with 1–3 items missing on a 
trait, a score (0–9) was imputed based on the distribution of the provided responses. 
4.1.4.2 Occupational stress 
Indicators of occupational stress were derived from a job exposure matrix (JEM), which was 
developed based on a random sample of 12,084 employed Swedish citizens aged 25 to 74 
years who answered the Swedish Survey of Living Conditions collected by Statistics Sweden 
in 1977 and 1979. The response rate was 81% in 1977 and 89% in 1979. The JEM was 
developed by aggregating survey responses of individuals to arrive at occupationally 
representative scores of job control and job demands for 261 occupational categories. As 
work conditions differed markedly between men and women within the same occupation, two 
different JEMs were developed—one for each sex. The job‐control scale was based on 12 
items and measured job authority and skill discretion. The job‐demand scale was based on 
two items on hectic time schedule and psychological demands. Both scales were 
multiplicatively transformed into continuous scales that could possibly range from 0 to 10.  
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The appropriate JEM was then used to assign scores to each individual in the study 
population based on their sex and the occupation reported in the 1980 or 1970 census. 
Occupations were coded according to the Nordic version of the 3‐digit International Standard 
Classification of Occupation manual. Information was primarily taken from the 1980 census, 
but for those not having an occupation registered in the 1980 census, information about 
occupation was retrieved from the 1970 census (8% of the cohort).  
4.1.4.3 Stress-related disorders 
We defined stress-related disorders as any first outpatient or inpatient hospital visit with the 
main diagnosis of a stress-related disorder according to the Swedish revisions of the ICD-9 
codes 308 and 309, or ICD-10 code F43 as recorded in the NPR.  
We then divided stress-related disorders into PTSD, acute stress reaction, and adjustment 
disorder and other stress reactions. ICD used to identify PTSD, acute stress reaction, and 
adjustment disorder are shown in Table 2 which also provides an overview of how these are 
defined in ICD-10. Other stress reactions (ICD-9: 309X; ICD-10: F43.8 and F43.9) include 
unspecified reactions to stress and exhaustion disorder which is only present in the Swedish 
version of ICD-10. These were classified together with adjustment disorder in the analyses.  
As PTSD may initially be preceded by other stress-related disorders, we considered all 
exposed individuals who received a PTSD diagnosis within 1 year after their first stress-
related disorder diagnosis as individuals with PTSD.  
4.1.4.4 Covariates 
In the statistical analyses of study I, III and IV we adjusted for several covariates to control 
for confounding and tested for potential mediation and interaction effects. In Study I, we 
adjusted for sex, smoking status (ever vs. never smoker), education (mandatory vs. higher 
education) and total number of hospital visits. In Study II, we adjusted for sex, education 
(elementary schooling, upper secondary schooling or university/college) and lifetime chronic 
obstructive pulmonary disease (as a proxy for smoking). In Study IV, we adjusted for 
educational level (<9, 9-12, >12 years, or unknown), family income (top 20%, middle, lowest 
20%, or unknown), marital status (single, married/cohabiting, or divorced/widow), history of 





Table 2. Brief overview of stress-related disorders.  















Trigger Exceptional physical 





likely to cause 
distress in almost 
anyone 
 
One or many 
identifiable stressors 
(e.g. life events) 
Time aspect Immediate and 
Transient 
 
Delayed or protracted, 
chronic 
Symptoms arise 
within 1 month. Do 
not persist more than 
6 months after 
termination of the 












(repeated reliving of 
the trauma), 








of activities and 
situations reminiscent 
of the trauma 
Significant distress, 
impairment in social 
functioning, a feeling 
of inability to cope, 
plan ahead, or 
continue in the 
present situation. 
Some degree of 
disability in the 
performance of daily 
routine. Emotional 
symptoms (depressed 
mood, anxiety and/or 
worry) 
 
4.1.5 Outcome ascertainments 
4.1.5.1 Parkinson’s disease 
In study I and III, incident cases of PD were defined as having a primary diagnosis of PD in 
the NPR or PD as the underlying cause of death in the CDR. ICD codes for PD were the 
following: 342.00 (ICD‐8), 332.A (ICD‐9), G20 (ICD‐10). The date of ascertainment was 
defined as the first date of any PD diagnosis in the NPR or date of death in the CDR for those 
cases only identified at death. 
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4.1.5.2 Neurodegenerative diseases 
In study IV, we defined incident neurodegenerative diseases as the first outpatient or inpatient 
hospital visit with a diagnosis of a neurodegenerative disease with corresponding ICD-9 or 
ICD-10 codes, as recorded in the NPR (Table 3). We categorized neurodegenerative diseases 
according to their potential origin, including primary neurodegenerative diseases and 
neurodegenerative diseases with a primary vascular cause. We also separately studied AD, 
PD, and ALS. Individuals who received two neurodegenerative disease diagnoses during the 
follow-up contributed to the analyses of both outcomes. 
 
Table 3 ICD codes used to identify neurodegenerative diseases 





F00, F02.0, F02.3, 
G12.2, G20, G23.1, 
G23.2, G23.8, G23.9, 
G25.9, G30, G31.0, 
G31.1, G31.8A, 
G31.9 
209A, 209B, 331A, 
331B, 331C, 331X, 
332A, 333A, 335C 
Vascular F01, G21.4 290E 
Other F03, F05.1 290W, 290X 
Selected neurodegenerative diseases:   
Amyotrophic lateral sclerosis  G12.2 355C 
Alzheimer's disease  F00, G30 290A*, 290B*, 331A 
Parkinson's disease  G20 332A 
* If found as the primary diagnosis 
 
4.2 GWAS DATA AND MEASUREMENTS 
For Study II we used summary-level data from published genome-wide association studies 
(GWAS) meta-analyses. GWAS are observational studies investigating the association 
between a set of genetic variants, usually single nucleotide polymorphisms (SNPs), and 
specific traits (e.g. neuroticism, smoking initiation and PD). 
4.2.1 Neuroticism GWAS 
We extracted summary statistics for genetic variants influencing neuroticism levels identified 
from a recent GWAS meta-analysis on neuroticism.8 This study reported 136 independent 
genome-wide significant loci (p<5×10-8) in a sample of 449,484 individuals of European 
descent, comprised of data from the UK Biobank (UKB) (n=372,903),22 23andMe, Inc. 
(n=59,206),23 and Genetics of personality consortium (GPC) (n=17,375).24 In the current 
study, we used summary statistics based on analyses excluding 23andMe data, as these 
summary statistics were publicly available and have no sample overlap in the two-sample 
MR analyses.  
Information on neuroticism was obtained through digital questionnaires in all samples: 12 
yes/no items of the Eysenck Personality Questionnaire-Revised Short form (EPQ-RS) for 
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UKB and 12 five-point Likert-scale items from the Neuroticism Extraversion Openness-Five 
Factor Inventory (NEO-FFI) for GPC.   
4.2.2 Smoking GWAS 
We used publicly available summary statistics from a recent GWAS meta-analysis of 
smoking behaviors to extract summary statistics of genetic variants influencing smoking 
initiation. This is a binary phenotype defined as having ever been a regular smoker or not. 
The study reported 378 independent genome-wide significant loci (p<5×10-8) in a sample of 
1,232,091 individuals of European descent.25  
4.2.3 PD GWAS  
We extracted summary statistics of associations between identified SNPs and PD from a 
large GWAS meta-analysis. Datasets included in this meta-analysis were the same as in a 
large recent PD GWAS meta-analysis10 excluding proxy PD-case data from the UK Biobank 
(UKB) and a smaller sample from the System Genomics of Parkinson's Disease (SGPD) 
whose data were not shared publicly. The data included 23andMe PD case-control summary 
statistics, which were provided by 23andMe under an agreement with 23andMe that protects 
the privacy of the 23andMe participants. This resulted in GWAS summary statistics data for 
36,752 PD cases and 929,806 controls of European ancestry.  
PD was either defined by self-report or by clinical diagnosis. The study included 9,157 self-
reported PD cases and 822, 855 controls from 23andMe and 27, 595 clinical diagnosis PD 




5 STUDY DESIGNS AND STATISTICAL METHODS 
 
5.1 COHORT STUDIES 
Cohort studies follow a group of people over a certain amount of time to compare the 
incidence, rate or time to event. It is a longitudinal design, in which exposed and unexposed 
are followed prospectively for the occurrence of an outcome, and each member of the cohort 
contributes with individual person-time during the follow-up period. Cohort members are 
censored when they no longer contribute to person-time at risk for the outcome. Using PD as 
an outcome, which is chronic, members are censored when they receive their first PD 
diagnosis, die from other causes or are lost to follow-up. Due to the prospective design, 
cohort studies are generally less prone to bias, specifically recall bias, compared to, for 
example, case-control studies.   
5.1.1 Personality and PD – Twin cohort 
In study I, we used a traditional cohort design to explore whether neuroticism and 
introversion were related to the risk of PD. The study population was comprised of a birth 
cohort of same-sexed twins from the STR, born in Sweden between 1926 and 1958, who 
responded to a mailed questionnaire in 1973 covering demographic, medical and lifestyle 
factors, as well as personality. Twins who were residing in Sweden and not previously 
diagnosed with PD (according to records from the NPR) at the start of follow-up (January 1st, 
1974) were eligible to enter the study cohort (n = 36,409). In total, 436 persons were 
excluded due to migration during follow-up or because it was not possible to link their data. 
Among the remaining population, 6,121 twins did not provide sufficient questionnaire data 
on the personality assessment and were excluded. This resulted in a study population of 
29,852 individuals.  
Associations with PD were analyzed using time-to-event methods with attained age as the 
underlying time scale. Risk time, expressed in terms of person-years, was accumulated from 
the date of study entry (January 1st, 1974) until first recorded PD diagnosis, death or when 
follow-up ended (December 31st, 2010), whichever came first.  
Neuroticism and introversion were treated both as continuous variables and as categorical 
variables divided into quartiles based on the distribution of the data. The quartile of lowest 
scores was used as the reference group. We also tested for a linear trend across quartiles.  
5.1.2 Occupational stress and PD – Population-based cohort 
In study II, we also used a traditional cohort design to explore associations between 
occupational stress and risk of PD. Study II included all individuals born in Sweden between 
1920 and 1950, who had an occupation linkable to a job exposure matrix reported in the 
Population and Housing Census in 1980 or 1970 and were living in Sweden at the start of 
follow-up on January 1st 1987 (n = 2,578,971). Individuals with a recorded PD diagnosis 
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from the NPR (n = 1,089) and individuals who were not continuously living in Sweden prior 
to the start of follow-up (n = 33,134) were excluded. This resulted in a final study cohort of 
2,544,748 individuals.  
All study participants were followed from baseline, (January 1st, 1987) until a diagnosis of 
PD or censoring (date of death, emigration or end of follow-up on December 31, 2010), 
whichever came first. Associations with PD were analyzed using time-to-event methods with 
attained age as the underlying time scale.  
Control and demands were analyzed as categorical variables divided into tertiles with the 
lowest tertile used as the reference group. The combination of demands and control was 
further analyzed as a categorical variable by combining high and low (median split) levels of 
demands and control into four job-strain groups; low-strain jobs (low demands, high control), 
passive jobs (low demands, low control), active jobs (high demands, high control), and high-
strain jobs (high demands, low control). 
5.1.3 Stress-related disorders and PD – Matched cohort design 
In study IV, we examined the association between stress-related disorders and PD risk by 
performing a population-matched cohort study to compare the risk of neurodegenerative 
diseases between individuals with and without a diagnosis of a stress-related disorder. 
Matching by confounding variables is an efficient way to adjust for confounding by design. 
Matching can also occur naturally, such as in full-siblings who share on average 50% of their 
co-segregating alleles and many environmental factors, especially factors related to 
upbringing. Matching is therefore a way to make use of family-clustered data to control for 
all confounding variables that are shared between the family members. Thus, to assess the 
role of unknown and unmeasured confounders, we also analyzed a sibling cohort to compare 
the risk of neurodegenerative diseases between individuals with stress-related disorders and 
their unaffected full siblings.  
We identified an exposed group of all Swedish-born individuals who received their first 
diagnosis of a stress-related disorder between January 1st, 1987, and December 31st, 2008 (n = 
99,714). We defined stress-related disorders as any first outpatient or inpatient hospital visit 
with a main diagnosis of a stress-related disorder. We then divided stress-related disorders 
into PTSD, acute stress reaction, and adjustment disorder and other stress reactions (see 
section 4.1.4.3). Exposed persons with a history of neurodegenerative diseases (n = 199) or 
with conflicting (n = 13) or missing (n = 15) information were excluded from the analysis. To 
ensure a complete familial link from the MGR, we excluded individuals who were born 
before 1932 (n = 6,311). Because the incidence rates of neurodegenerative diseases were low 
among individuals aged 40 years or younger, we also excluded individuals who were too 
young at index date to reach age 40 during the follow-up period (n = 27,072), leaving 66,017 
eligible individuals in the exposed group. 
Population-Matched Cohort: Individuals with stress-related disorders were compared with 
the general population in a matched cohort design. For each exposed person, 10 individuals 
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free of stress-related disorders and neurodegenerative diseases at the diagnosis date of the 
index person were randomly selected from the TPR using the method of incidence density 
sampling (n = 660,170). Exposed and unexposed individuals were individually matched by 
birth year, sex, and county of birth. 
Sibling Cohort: Individuals with stress-related disorders were also compared to their full-
siblings in a sibling cohort. Through the MGR, we identified all clusters of full siblings that 
were discordant for stress-related disorders, including a total of 92,643 full siblings of the 
47,591 individuals with stress-related disorders who were free of stress-related disorders and 
neurodegenerative diseases at the diagnosis date of the affected sibling. 
The date of stress-related disorder diagnosis was used as the index date for the exposed 
individuals and their matched unexposed counterparts and unaffected full siblings. Because 
the incidence rates of the neurodegenerative diseases were low among individuals aged 40 
years or younger and diagnostic delays were common for these diseases, we started the 
follow-up of the study participants from age 40 years or 5 years after the index date, 
whichever came later, until the first diagnosis of a neurodegenerative disease, death, 
emigration, or the end of follow-up (December 31st, 2013), whichever occurred first. This 
method also rendered a better control for potential surveillance bias, assuming a greater than 
expected surveillance of neurodegenerative diseases and other diseases compared with the 
diagnostic workup and treatment for stress-related disorders. For the matched unexposed 
individuals and unaffected full siblings, the follow-up was additionally censored at their first 
diagnosis of a stress-related disorder, if any, during the follow-up. 
5.1.4 Cox proportional hazard regression 
Cox proportional hazards regression, yielding hazard ratios (HR) with 95% confidence 
intervals (CI) was used to evaluate possible associations between exposures and outcome in 
Study I, III and IV. Cox regression estimates the hazards (i.e. incidence) across an underlying 
time scale, and the HR are ratios of event rates between different exposure groups. In study I 
and III, attained age was used as the underlying time scale, thus the HR were automatically 
adjusted for age. HRs were interpreted as measures of relative risk. 
In study I, we also used a conditional Cox regression model to test for confounding by 
familial factors shared within twin pairs. Twin pair id was used as the stratum variable, 
thereby fixing an individual baseline hazard within each pair of twins while at the same time 
allowing it to vary between twin pairs.134 An attenuation of any observed effect would 
suggest that familial factors contribute to the association, while persistence of the effect 
would suggest an independent effect of personality on PD incidence. Only complete twin 
pairs discordant for personality and PD diagnosis contributed to the within twin pair analyses. 
In study IV, we used conditional Cox regression models, using time after the start of follow-
up as the underlying time scale, stratifying analyses by matching identifiers (age, sex, and 
county of birth). In the sibling cohort of study IV, we used Cox regression models stratified 
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by family identifiers. (In study IV, age was controlled for by matching (population matched) 
or by adjusting for birth year (sibling cohort)). 
One key assumption of Cox regression is that the HR are assumed to be constant over the 
follow-up time. The assumption of proportional hazards was assessed using the Thernneau 
and Grambach test of the Schoenfeld residuals.135 No evidence of non-proportionality was 
found. A robust sandwich estimator of the standard errors was used to account for the 
dependence between observations in the twin data (for Study I). 
5.1.5 Mediation analysis 
In study I, we investigated the role of smoking as a mediator in the relationship between 
personality trait and PD by performing a mediation analysis according to the approach 
suggested by Lange et al.136 This analysis decomposes the total effect of an exposure into 
estimates of the so-called natural direct and indirect effects using nested counterfactuals. The 
natural direct and indirect (i.e. mediated through smoking) effects were calculated adjusting 
for sex as a baseline confounder and using attained age as the underlying time scale. The 95% 
CIs were calculated using a bootstrap method with 1,000 replications.  
5.2 MENDELIAN RANDOMIZATION DESIGN 
Observational epidemiological studies inevitably suffer from potential biases, such as 
confounding and reverse causation, which limit the ability to determine causality. 
Randomized controlled trials (RCT) are considered the gold standard for causal inference. 
Randomizing exposures is however not always ethically (or economically) motivated or even 
practically feasible. Mendelian randomization (MR) design is an application of instrumental 
variable analysis used to infer causality from observational studies. In MR, the association 
between an exposure and outcome (e.g. neuroticism and PD) is estimated by using a third 
variable (e.g. SNPs) as an instrument for the exposure that is independent of the confounders 
between the exposure and outcome. The MR design makes use of the principle that genotypes 
are not generally susceptible to reverse causation and confounding due to their fixed nature. 
Further it makes use of Mendel’s laws of segregation and independent assortment of alleles 
as a sort of natural randomized experiment.  
The essential assumptions for MR inference are: (i) The genetic variant (e.g. SNP) has a 
causal effect on the exposure (e.g. neuroticism). (ii) The genetic variant (e.g. SNP) affects the 
outcome (e.g. PD) only through the potential effect on the exposure (e.g. neuroticism) (iii) 
The genetic variant and the outcome do not have common causes. 




5.2.1 Two-sample MR 
MR studies generally require very large sample sizes as the genetic variants usually explain a 
very small proportion of the variance in the exposure. Two-sample MR methods use data on 
gene-exposure and gene-outcome associations from different samples.137 Thus, previously 
published genome-wide association studies (GWAS) of exposure and outcome can be 
combined to increase sample size and power. 
In study II, we aimed to explore the causal association between neuroticism and PD and the 
role of smoking as a potential mediator in this relationship using a two-sample MR approach 
and GWAS summary statistics. Analyses were performed in a network framework consisting 
of three main analyses: (i) causal effect of neuroticism on PD using SNPs associated with 
neuroticism, (ii) causal effect of neuroticism on smoking initiation using SNPs associated 
with neuroticism, (iii) causal effect of smoking initiation on PD using SNPs associated with 
smoking initiation (Figure 5-1).  
Figure 5-1 Network Mendelian randomization
 
IV = Instrumental Variable 
5.2.2 Statistical methods 
The main statistical method in Study II was the inverse variance weighted (IVW) method.137 
The IVW estimate of the causal effect (?̂?IVW) combines the ratio estimate from multiple 
variants (SNPs) and can be seen as a weighted average of ratio estimates Yk/Xk for each SNP. 
 













K Number of SNPs 
Xk Effect of kth SNP on X (neuroticism) 
Yk  Effect of kth SNP on Y (PD) 




6 MAIN RESULTS AND STUDY SUMMARIES 
 
6.1 STUDY I – NEUROTICISM, INTROVERSION AND RISK OF PD 
6.1.1 Objectives 
In study I, we explored the effects of neuroticism and introversion on later risk of PD. 
Additionally, we investigated the mediating effect of smoking. Lastly, we explored the 
potential confounding effect of familial factors shared by twins. 
6.1.2 Method 
A population-based cohort study was conducted using questionnaire data from the Swedish 
Twin Registry for twins born 1926-1958 (n = 29,852). Personality traits were assessed in 
1973 by a short form of Eysenck’s Personality Inventory. The cohort was followed from 
1974 to 2012 through the NPR and CDR for PD ascertainment. Cox proportional hazards 
regression with attained age as underlying timescale was used to estimate HRs for PD. 
Models were further adjusted for sex, smoking, education, and number of hospital visits. A 
mediation analysis was performed to further explore the role of smoking in the relationship 
between personality traits and PD. Confounding by familial factors was explored using a 
within twin pair analysis. 
6.1.3 Main results 
During a mean follow-up time of 36.8 years (SD = 6.1) we identified 197 incident PD cases. 
Mean age at personality assessment was 30.2 years (SD = 9.2) and mean age at PD 
ascertainment was 67.6 years (SD = 8.9).  
Neuroticism was associated with an increased risk of PD. The relationship between 
neuroticism and PD seemed to be more pronounced in women, although the interaction term 
between sex and neuroticism was not significant (Figure 6-1). In women, there was also a 
significant linear relationship (HR: 1.09, 95%CI: 1.01-1.18).  
There was a significant linear relationship between introversion and PD risk (HR: 1.07, 
95%CI: 1.01-1.14) and a significant trend across quartiles (p=0.04) in the overall population. 
The HRs were higher in women than in men, but none were significant, including the 
interaction term (p = 0.67) (Figure 6-2). 
Results from the mediation analysis indicated that the indirect effect of neuroticism through 
smoking was protective for PD. Therefore, the direct effect of neuroticism was stronger than 
the total effect. Lastly, the HRs in the within twin pair analyses dropped compared to the 




Figure 6-1 Hazard ratios and 95% confidence intervals for PD in relation to neuroticism. 
* Attained age was used as the underlying timescale and models were further adjusted for sex and smoking 
status. Education and number of hospital visits (for all causes) were not statistical confounders and were not 




Figure 6-2 Hazard ratios and 95% confidence intervals for PD in relation to introversion. 
* Attained age was used as the underlying timescale and models were further adjusted for sex and smoking 
status. Education and number of hospital visits (for all causes) were not statistical confounders and were not 




6.2 STUDY II – NEUROTICISM, SMOKING AND RISK OF PD 
6.2.1 Objectives 
In study II, we wanted to explore whether associations between neuroticism, smoking and PD 
risk are causal.  
6.2.2 Method 
Based on summary statistics from GWAS meta-analyses on large cohorts of European 
ancestry we applied a two-sample MR design in a network framework, consisting of three 
main analyses: (I) causal effect of neuroticism on PD, (II) causal effect of neuroticism on 
smoking initiation, (III) causal effect of smoking initiation on PD. The inverse variance 
weighting method was used as the main method to estimate the causal effects. 
6.2.3 Main results 
The main results of this study are presented in Figure 6-3. We found no evidence for a causal 
effect of neuroticism on PD risk. However, we found a significant effect of neuroticism on 
smoking initiation (OR: 1.10, 95% CI: 1.05 to 1.14). Further, our results provided evidence 
for a protective effect of smoking initiation on PD risk (OR: 0.75, 95% CI: 0.62 to 0.91). As 
there were significant associations between both neuroticism and increased smoking initiation 
and between smoking initiation and reduced PD risk, the total effect of neuroticism on PD 
risk may be an underestimation of the direct effect. However, since the observed total effect 
of neuroticism on PD was negative (non-significant), and the indirect effect was also weakly 
negative, the direct causal effect of neuroticism on PD risk may be even closer to unity.  
Figure 6-3 Estimates of the total effect of neuroticism on PD risk and the mediating paths between neuroticism 
and smoking initiation and between smoking initiation and PD risk based on analyses using the IVW method. 




While we did not find a significant association between neuroticism and PD, one SNP, 
rs58879558 (located in MAPT region), was associated with both neuroticism and PD. This 
SNP was not included in the final analysis as it may violate the MR assumptions. However, it 
indicates presence of shared genetics between neuroticism and PD. 
6.3 STUDY III – OCCUPATIONAL STRESS AND RISK OF PD 
6.3.1 Objectives 
In study III, we explored the association between occupational stress according to the job 
demands-control model and risk of PD. 
6.3.2 Method 
We conducted a population-based cohort study with 2,544,748 Swedes born 1920-1950 who 
had an occupation reported in the Population and Housing Censuses in 1980 or, if missing, in 
1970. Job demands and control were measured using a job-exposure matrix. Incident PD 
cases were identified through Swedish national health registers between 1987 and 2010. Data 
were analyzed with Cox regression with age as the underlying time scale, adjusting for sex, 
education and chronic obstructive pulmonary disease as a proxy for smoking. 
6.3.3 Main results 
The study population consisted of 2,544,748 persons, who were followed on average for 
21.3 years (SD 5.5). During follow-up 21,544 incident PD cases were identified. High levels 
of job demands and job control were associated with an increased risk of PD in the overall 
sample (Table 4).  
Table 4. Hazard ratios and 95% confidence intervals for PD by job demands and job control in the overall 
population, adjusted for chronic obstructive pulmonary disease. 
Demands HR (95% CI)   Control HR (95% CI)  
 Low 1.00 Ref.   Low 1.00 Ref. 
 Middle 0.97 (0.94 - 1.01)   Middle 0.98 (0.95 - 1.02) 
 High 1.19 (1.15 - 1.23)   High 1.29 (1.25 - 1.33) 
 
However, we found significant interactions with both sex and education. Results from models 
including three-way interaction terms with sex and education indicated that high demands are 
only associated with PD risk among men, especially men with high education, whereas there 
is no significant effect of job demands on PD risk among women (Figure 6-4). In contrast, 
high control was only associated with increased PD risk among the low educated, more 




Figure 6-4 Hazard ratios and 95% confidence intervals for PD by job demands  
* Attained age was used as the underlying timescale, the model was further adjusted for chronic obstructive 
pulmonary disease and an interaction term with sex and education.  
 
 Figure 6-5 Hazard ratios and 95% confidence intervals for PD by job control 
 
* Attained age was used as the underlying timescale, the model was further adjusted for chronic obstructive 
pulmonary disease and an interaction term with sex and education.  
 
High strain jobs (combination of high demands and low control) were associated with PD risk 
in highly educated men only (HR: 1.25, 95%CI: 1.04-1.51), whereas active jobs 
(combinations of high demands and high control) were associated with increased PD risk in 
men with low education (HR: 1.20, 95%CI: 1.09-1.32). There were no associations between 




6.4 STUDY IV – STRESS-RELATED DISORDERS AND RISK OF 
NEURODEGENERATIVE DISEASES 
6.4.1 Objectives 
In study IV, we explored whether stress-related psychiatric disorders (PTSD, acute stress 
reaction, adjustment disorder, and other stress reactions) are associated with subsequent risk 
of neurodegenerative disorders, including PD.  
6.4.2 Method 
We conducted a population- and sibling-matched cohort study using data from nationwide 
health registers. Individuals who received their first diagnosis of a stress-related disorder 
between 1987 and 2008 were identified through the NPR. Individuals who had a history of 
neurodegenerative diseases, conflicting/missing information, no data on family links, or were 
younger than 40 at the end of follow-up were excluded. Neurodegenerative diseases were 
identified through the NPR and classified as primary or vascular. Alzheimer disease (AD), 
PD, and amyotrophic lateral sclerosis (ALS) were evaluated separately.  
Individuals with stress-related disorders were compared with the general population in a 
matched cohort design. They were also compared with their siblings (if having any) in a 
sibling cohort design. Follow-up started from the age of 40 or 5 years after the diagnosis of 
stress-related disorders, whichever occurred later. End of follow up was defined as the first 
diagnosis of a neurodegenerative disease, death, emigration, or December 31st, 2013, 
whichever occurred first. Cox proportional hazards regression models were used to estimate 
hazard ratios with 95% confidence intervals after controlling for multiple confounders.  
6.4.3 Main results 
In total, 61,748 exposed individuals and 595,335 matched unexposed individuals were 
included in the analysis of the population-matched cohort, whereas 44,839 exposed 
individuals and their 78,482 unaffected full siblings were included in the analysis of the 
sibling cohort. The median age at the start of follow-up was 47 years (interquartile range: 41-
56) and 39% of the exposed individuals were male. The median follow-up was 4.7 years 
(interquartile range: 2.1-9.8). 
Compared to unexposed individuals, individuals with a stress-related disorder were at an 
increased risk of neurodegenerative diseases. The risk increase was greater for vascular 
neurodegenerative diseases than primary neurodegenerative diseases. A statistically 
significant association was found for AD, but not PD or ALS. Results from the sibling cohort 
corroborated results from the population cohort (Figure 6-6). The cumulative incidence plot 
shows the temporal pattern of neurodegenerative diseases among exposed individuals and 
their matched unexposed counterparts (Figure 6-7). These curves indicate that the increased 
incidence of neurodegenerative disease was observed right after the beginning of follow-up 
and appeared to be constant throughout the entire follow-up period.  
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Figure 6-6 Hazard ratios with 95%CIs for neurodegenerative diseases among individuals with stress-related 
disorders vs matched unexposed counterparts or unaffected full siblings 
 
*HRs and 95%CIs were derived from Cox proportional hazards regression models, stratified by matching 
identifier (birth year, sex, and county of birth for population-matched cohort) and family identifier (for sibling 
cohort) and further adjusted for educational level, family income, marital status, history of psychiatric disorders, 
and family history of neurodegenerative diseases. Family history of neurodegenerative diseases was controlled 
for by design in the sibling cohort and not as a covariate. Time since start of follow-up was used as the 
underlying time scale.  
 
Figure 6-7 Standardized cumulative incidence of neurodegenerative diseases among individuals with stress-
related disorders (exposed) and their matched unexposed individuals (unexposed) 
 
*Standardized cumulative incidence was estimated for the exposed and unexposed individuals using regression 
standardization over covariates’ distributions, after fitting flexible parametric models and adjustment for birth 
year, sex, county of birth, educational level, family income, marital status, history of psychiatric disorders, and 







7.1 PERSONALITY AND PD 
In study I, we investigated whether neuroticism and introversion measured in early adulthood 
to early middle age are associated with higher risk of PD in the following four decades. We 
found a relatively strong effect of neuroticism on PD risk, especially among women, whereas 
the effect of introversion was weaker. Our results for neuroticism are in line with a previous 
longitudinal study with over four decades of follow-up reporting a higher risk of PD related 
to neuroticism,68 whereas a similar longitudinal study found no effect of introversion on PD 
risk.69  
It has been suggested that a part of the association between neuroticism and health in general 
partly could be explained by the fact that neurotic individuals perceive and report symptoms 
differently which would represent some sort of nuisance factor.138 139 Although it is unlikely 
that neurotic people will be misclassified as PD cases, neuroticism could influence the 
proneness to seek medical care which would influence the probability of being ascertained 
with the disease. We addressed this issue by counting and adjusting for the total number of 
hospital visits for causes other than PD during follow up. Indeed, neuroticism was associated 
with increased number of hospital visits. However, it did not influence the association with 
PD.   
Another potential mechanism is mediation by health-related behaviors. However, given what 
is known about health-related behaviors related to neuroticism and known risk factors for PD, 
it is not clear what kind of factor that would mediate this association, as most of them would 
lead to a decreased PD risk. In fact, adjusting for smoking strengthened the association 
between neuroticism and PD risk and smoking was a significant mediator (suppressor) in this 
relationship. Education, which predicts various health behaviors and outcomes and may be 
used as an indicator of socioeconomic status, did not confound the association between 
personality and PD. Another hypothesis that we were not able to address in study I is 
mediation by stress, as neurotic individuals are more prone to stress and stress is a suggested 
risk factor for PD.106-108  
Another potential explanation for the observed association between personality and the risk 
of PD is confounding by familial factors, such as shared genes or familial environment. 
Therefore, we performed a within twin pair analysis. Unfortunately, the sample size was 
markedly reduced in the within pair analyses limiting firm conclusions. However, we found 
that the estimates tended to drop compared to the initial cohort analyses which would indicate 
that the results may partly be explained by familial factors. This finding needs to be 
confirmed.  
Finally, the observed associations between personality traits and PD could be explained by 
reverse causation. Since the personality traits were measured relatively early in life and we 
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had a long follow-up, the possibility of reverse causation is less likely compared to many 
other studies. However, since the personality trait was only measured once and the prodromal 
period of PD is very long, the possibility of personality changes as a prodrome could not be 
ruled out.  
Therefore, in study II we wanted to examine whether the observed associations between 
neuroticism, smoking and PD risk from study I were causal using a network MR design to 
estimate the total effect of neuroticism on PD risk, as well as to assess the direct effect and 
indirect effect through smoking.  
We found no evidence in support of a causal effect of neuroticism on PD risk. However, one 
SNP, rs58879558 (located in MAPT region), was associated with both neuroticism and PD. 
When excluding this variant in the MR analysis, the magnitude of the association was 
considerably attenuated, implying that genetics play an important role in the observed 
associations in conventional epidemiological studies and the variant may exhibit pleiotropic 
effects in MR analysis. Previous studies using bivariate linkage disequilibrium (LD) score 
regression reported no genetic correlation between neuroticism and PD42 whereas gene-set 
analysis revealed enrichment of genes associated with neuroticism in sets of genes that have 
previously been implicated in PD.61 It is therefore crucial to take genetic confounding into 
account when examining the role of neuroticism in PD.  
In Study II, we also found significant associations between neuroticism and smoking 
initiation, and between smoking initiation and PD risk, which is in line with the results from 
study I of an indirect path between neuroticism and PD risk through smoking.  
Our results are supported by several observational cohort studies associating neuroticism with 
increased smoking behaviours.140 A previous MR study using ten SNPs as instrumental 
variables for neuroticism reported that neuroticism was associated with increased odds ratio 
for smoking initiation although the results were not statistically significant.74 Study II, 
empowered with more SNPs as instrumental variables and a larger sample size for smoking 
initiation, updates previous findings and provides additional evidence for the causal 
association between them.  
Our finding that smoking initiation was associated with a reduced risk of PD is also supported 
by previous MR studies reporting a reduced risk of PD for ever smokers141 and for smoking 
initiation.42 Further, numerous observational studies have consistently showed a reduced risk 
of PD in relation to smoking.45 Several explanations have been suggested for this association, 
including residual confounding and reverse causation such that individuals with prodromal 
PD are less likely to start smoking or more likely to quit.50 However, some findings from 
observational studies support a causal effect of smoking on PD. For example, smoking 
intensity and duration are both related to PD risk reduction,46 and passive smoking among 
never smokers has also been associated with reduced PD risk.49 Further, smoking has also 
been associated with reduced PD risk in co-twin control studies, reducing confounding due to 
genetic and familial environmental factors.142 Taken together, these findings support the 
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theory that smoking actually has a protective effect on PD risk. One should never over-
interpret the results of one single study. Likewise, one should not over-interpret the results 
from many studies using the same methodological approach. Each approach makes different 
assumptions and has its own keys sources of bias. Therefore, when it comes to causal 
questions, integrating results from different studies using different approaches to answer the 
same research question is the best option.143 
To summarize, neuroticism is associated with an increased risk of PD but this association is 
not likely to be causal. In study I, importance of familial factors in this association was 
indicated, although limited power precluded firm conclusions. However, in study II 
additional evidence for shared genetics between neuroticism and PD was provided. Further, 
we found evidence that genetic liability to neuroticism is associated with an increased 
tendency to start smoking regularly. Finally, our study provided evidence that genetic liability 
to smoking initiation is associated with a reduced risk of PD. 
7.2 STRESS AND PD 
 
7.2.1 Occupational stress 
In study III, we found that both high job demands and (somewhat unexpected) high job 
control were associated with increased PD risk in the overall sample. However, we also found 
significant interaction effects with both sex and education. After taking this into 
consideration, high job demands was only associated with PD risk among men, especially 
men with high education. In contrast, high control was only associated with increased PD risk 
among people with low education, especially among women. Accordingly, high strain jobs 
were only associated with increased PD risk among highly educated men, whereas active jobs 
were associated with increased PD risk among men with low education. 
Thus, the results for job control are contrary to the hypothesis and are not easily interpreted. 
This could of course mean that occupational stress defined by low control could have 
beneficial effects on PD risk. Alternatively, high control and especially the aspect of job 
authority may lead to more interpersonal conflicts and more work-to-home interference 
which would induce more stress.144 Thus, the effect of job control may vary depending on 
various organizational, individual or social factors. In line with this hypothesis, studies have 
also shown that high control or active jobs were associated with negative health outcomes in 
women, for example depressive symptoms,145 coronary heart disease146 and increased 
mortality.147 Due to inequalities in the labor market, it is possible that women did not derive 
the same benefits of positions of authority as men,148 which would explain why the positive 
effect of high control on PD risk was stronger in women compared to men, and stronger in 
those with low education compared to higher education. Further, the job demand-control 
model has been criticized for being more valid for men, with generally larger effect sizes or 
effects only present in men.87 89 Thus, this could explain why we only found associations 
between high strain jobs and PD risk in men. 
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Another potential explanation is confounding by traits that predispose both to seeking 
specific types of jobs and to increased PD risk, such as personality. However, a study using 
choice of occupation as a proxy for personality found no evidence for an association between 
occupation-derived personality traits and PD.149   
To summarize, our findings suggest that occupational stress is related to PD risk; high 
demands with increased risk and low control with decreased risk. The effects were dependent 
on sex and education. Thus, this highlights the importance of considering interaction effects 
between sex, education or other indicators of socioeconomic position with occupational stress 
in future studies and not only consider them as confounders as often have been done. The 
results from study III are intriguing, and one can only speculate about potential explanations 
for the observed associations. As this study is the first to explore the association between 
occupational stress and risk of PD, we cannot compare our results with others which is 
required to draw firm conclusions. To better understand the relationship between 
occupational stress and PD risk, more studies are motivated and future studies may consider 
other models of occupational stress in order to elucidate whether occupational stress only is a 
risk factor for PD or if there are also aspects of stress that may be protective. 
7.2.2 Stress-related disorders 
In study IV, we found that stress-related disorders were associated with an increased 
subsequent risk of neurodegenerative diseases. This association was robust and remained 
after adjustment for potential confounders, including demographic, health-related and familial 
factors. The stronger association observed for neurodegenerative diseases with a vascular 
component compared to primary neurodegenerative diseases suggested a considerable role of 
a possible cerebrovascular pathway.  
Our finding that individuals with a stress-related disorder were at an increased risk of 
developing a neurodegenerative disease gains support from previous studies.95-102 104 
However, most of the previous research has focused solely on PTSD95-100 102 and dementia,96-
101 and were often derived from studies of male veterans, who differ significantly from the 
general population and in terms of trauma exposure.95-98 
For specific neurodegenerative diseases, we found a statistically significant association for 
AD but not for PD or ALS. Although the estimates for PD, as well as for ALS, implied an 
increased risk in relation to stress-related disorders, the associations were not statistically 
significant. This might be partly attributable to the relatively young cohort and the low 
incidence of PD and ALS at early age. Although our results for PD should be interpreted with 
caution, taken together with previous findings of an increased PD risk in relation to 
adjustment disorder and PTSD, this question deserves further attention. 
Stress-related disorders are a major public health problem in itself, which leads to suffering 
for the affected individual and costs for the society. Thus, preventing and treating stress-
related disorders is important to reduce suffering from the stress in itself. Potentially, this 
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could also have an effect on other health outcomes as well, such as reduced numbers of 
neurodegenerative disorders.  
7.3 METHODOLOGICAL CONSIDERATIONS 
7.3.1 Misclassifications 
The quality of the data is the most important factor to consider as no study design or 
statistical method can fix the problem of poor data. Measurement errors may lead to 
misclassification bias. If misclassifications are independent of other variables, it is called non-
differential misclassification and generally biases results towards the null. If 
misclassifications are related to other variables (e.g. exposures) it is referred to as differential 
misclassification, which is a more severe concern as it can bias the results in both directions.  
In study I and III, the outcome measures were derived from the NPR and CDR. A previous 
validation study concluded that the NPR and CDR are valid data sources in epidemiological 
studies of PD with generally good accuracy and sensitivity.150 The positive predictive value 
(PPV) of an inpatient PD diagnosis (primary or secondary) was 70.8% compared to the gold-
standard clinical work-up, and the PPV increased to 80.3% when restricted to primary 
inpatient diagnoses. The sensitivity of PD diagnoses in the NPR and CDR combined was 
83.1%.150 Although misclassification of PD diagnoses in registers occur, for Study I and III 
they are most likely non-differential and would bias our results towards the null.151    
In study IV, both exposures and outcomes were derived from the NPR. Diagnoses of stress-
related disorders have not been validated. Although validation studies have shown 
satisfactory to excellent positive predictive values for neurodegenerative diseases identified 
through the NPR, the sensitivity of these diagnoses, especially dementia (i.e., 50% for 
dementia diagnosis based on inpatient care records152) is low. This misclassification would, 
however, most likely bias the studied associations towards the null.151 Further, the register-
based definitions of stress-related disorders and neurodegenerative diseases might have 
included patients with more severe stress-related disorders or neurodegenerative diseases 
compared to all patients with these diseases. This might be especially relevant for the period 
of 1987-2000 when these diseases were only ascertained through inpatient hospital visits. 
Therefore, the association of stress-related disorders with milder forms of neurodegenerative 
diseases, as well as the generalizability of our findings to individuals with milder stress-
related disorders, need further investigation. As both exposures and outcomes were derived 
from the NPR in Study IV, it is possible that having the first diagnosis increases the 
likelihood of the receiving the other. To deal with potential surveillance bias, we started the 
follow-up of the study participants at the earliest 5 years after the index date. 




7.3.2 Validity and generalizability 
External validity refers to the extent to which the results from one study can be generalized to 
other populations, situations, and times. External validity is strengthened if the findings can 
be reproduced in other settings. The results from Study I, that neuroticism and similar traits 
are associated with PD risk, have been found in other populations as well, which strengthens 
the validity of these results. It has been questioned whether results from twin cohorts (as in 
Study I) could be generalized to the general population. However, a large Swedish study 
reported no differences in morbidity and mortality when twins were compared with 
singletons, indicating that findings from twins could be generalized to the general 
population.153 The findings of study IV are also supported by similar findings from other 
studies on other populations. The finding of study III is novel and we do not know whether 
these results would replicate in other populations or times. It is for example possible that 
structural differences between countries and changes on the labor market over time would 
interfere with our results.   
Results from MR studies should not be over-interpreted in practice. It is important to keep in 
mind that MR studies estimate the effects of the genetic liability of a trait on an outcome. 
That does not have to be the same as the effect of the actual trait. However, in Study I and II 
we were able to replicate findings of an associations between neuroticism and smoking and 
between smoking and PD using different methodological approaches which increases the 
validity of our conclusions. 
7.3.3 MR assumptions 
The validity of Study II mainly concerns the general assumptions of MR analysis. The first 
assumption, that the SNPs used as instrumental variables must be associated with the 
exposure, is the only testable assumption. We only used SNPs that were associated with the 
exposures at genome-wide significance, which makes this assumption more likely to hold. 
The second assumption is that the SNPs should not be associated with any confounding 
factors between neuroticism, smoking initiation and PD. MR studies are less vulnerable to 
confounding compared to observational studies given the random assortment of alleles. 
However, violation of this assumption is possible and cannot be ruled out. One important 
potential cause of violation to this assumption is population stratification. However, we only 
included data based on participants of European ancestry thus reducing this potential bias. 
The third assumption is that the SNPs should only affect the outcome through the exposure, 
i.e. there should be no pleiotropy. To address this issue, we used additional MR models that 
allow for different types of genetic pleiotropy and make different assumptions regarding 
instrument validity. As these different models produced similar causal effect estimates, our 




7.4 ETHICAL CONSIDERATIONS 
Ethical considerations in medical research must always be taken seriously. In epidemiological 
research using sensitive personal data the main concern is ensuring the personal integrity of 
participants. All studies using sensitive personal data (Study I, III, IV) needed an approval 
from the Regional Ethics Committee. Summary statistics data, which were used in Study IV 
are not covered by the general data protection regulation (GDPR) or the ethical review act. 
Nevertheless, all studies in this thesis were approved by the Regional Ethics Review Board in 
Stockholm.  
For Study I, based on questionnaire data from the STR, informed consent was obtained from 
all participants. Further, twins in the STR have the right to opt out from the register at any 
time. For Study III and IV, which are registry-based studies, informed consent is not required 
according to Swedish law and obtaining consents from participants in a nationwide cohort 
study would not be feasible. Individuals included in Swedish national registers have no 
possibility to opt out, and might not even know that they are included in these registers and 
thus included in research projects. The potential harm and benefit should always be carefully 
weighed in all studies. As register-based research has an important value for society, and the 
risk of physical harm or discomfort for the individual is minimal, the benefits often outweigh 
the potential harm. However, it is crucial to ensure that data are handled safely and 
respectfully to make sure that the study participants’ personal integrity is not violated. That 
would have devastating consequences for the individual but also for the trust and belief in 
scientific research. There are strict regulations on how personal data are allowed to be 
handled. Data available to researchers are de-identified (personal identification numbers, 
names, addresses and other personal identifiers are removed) and reverse identification is 








8 CONCLUSIONS  
 
I.  Neuroticism and introversion measured in early adulthood to early middle age are 
associated with higher risks of PD in the following three decades. 
Smoking is a significant mediator in these relationships – acting as a suppressor for 
the effect of neuroticism on PD risk, whereas partly accounting for the association 
between introversion and PD risk. 
The observed effects of these personality traits on PD risk may partly be explained by 
familial factors shared by twins, although more data would be required to confirm or 
disprove this conclusion. 
II.  Neuroticism does not seem to have a causal effect on PD risk.  
Neuroticism seems to be causally related to an increased tendency to start smoking. 
This study supports the hypothesis that smoking has a protective effect on PD, rather 
than that the association is explained by residual confounding. 
III.  High job demands appear to increase PD risk in men, especially in men with high 
education.  
High job control increases PD risk among low educated, more strongly in women. 
High strain jobs (the combination of high demands and low control) is associated with 
increased PD risk in men with high education. 
Active jobs (combinations of high demands and high control) is associated with 
increased PD risk in men with low education.  
IV. Stress-related disorders were associated with increased risks of neurodegenerative 
diseases. The relative strength of the association for vascular neurodegenerative 
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QUESTIONS RELATING TO YOUR CHARACTER, FEELINGS AND ACTIONS 
Decide whether “yes” or “no” best corresponds to your character, feelings and actions. Do 
not spend too much time on each question. We are trying to determine your immediate 
reactions. 
  YES NO 
1 Do you like having a lot of things going on around you? □ □ 
2 Are you often uneasy, feeling that there is something you want without 
knowing it? 
□ □ 
3 Do you almost always have an answer ready when spoken to? □ □ 
4 Are you sometimes happy and sometimes sad without any special 
reason? 
□ □ 
5 Do you prefer to keep to the background in the company of other people? □ □ 
6 Do you regard yourself as happy and carefree? □ □ 
7 Do you often reach decision too late? □ □ 
8 Do you often feel tired and listless without any special reason? □ □ 
9 Do you have a lively manner? □ □ 
10 Can you quickly describe your thoughts in words? □ □ 
11 Are you often lost in your thoughts? □ □ 
12 Do you have anything against selling things or asking people for money 
for some charitable purpose? 
□ □ 
13 Are you extremely sensitive in any respects? □ □ 
14 Are you ever too restless to sit still? □ □ 
15 Do you keep things to yourself except with good friends? □ □ 
16 Do you have any nervous problems? □ □ 
17 Do you like to crack jokes and tell funny stories to your friends? □ □ 
18 Do you usually worry a long time after a distressing incident? □ □ 
Scoring 
Neuroticism: Rated by summing the numbers of “yes” in the questions 2, 4, 7, 8, 11, 13, 14, 
16 and 18. A high total score implies neuroticism. 
Introversion: Rated by giving one score for answering “no” in question 1, 3, 6, 9, 10, 17 and 
“yes” in question 5, 12, 15 and then adding up the total number of scores. A high total score 
implies introversion. 
 
